(1)
Myo, E.; Mohandas, C. Comparison of Subcutaneous GLP-1 Receptor Agonists, Semaglutide and Dulaglutide, on HbA1c and Weight Loss Outcomes: A Systematic Review. AJPP 2025, 5, 45-46.